Cashu
RedHill Biopharma Launches Talicia to Combat H. pylori Infections in the U.S.
about 1 month ago
Stocks
Health Care
rdhl
Redhill Biopharma
NASDAQ: RDHL
0.00 (+0.07%)
0.7452
USD
At close at Apr 01, 20:39 UTC
Latest Redhill Biopharma News
prnewswire.com
Joint U.S. Commercialization of RedHill's Talicia Commences
about 1 month ago
prnewswire.com
Argo Biopharma Announces First Patient Dosed in Phase 2b Trial of siRNA Therapeutic BW-20829 in Patients with Elevated Lp(a)
2 months ago
prnewswire.com
Global Biopharma Company Triples Research Commitment to Tishman Speyer and Breakthrough Properties' One Milestone at the Harvard Enterprise Research Campus, One of Boston's Most Anticipated New Developments
2 months ago
prnewswire.com
LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders
2 months ago
prnewswire.com
Mandara Biopharma Files IND with the FDA to Advance Dronabinol Oral Solution Formulation for Alzheimer's Agitation
3 months ago
prnewswire.com
Argo Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
3 months ago
benzinga.com
China's Biopharma Sector Enters New Year On A high
3 months ago
prnewswire.com
Biopharma's Innovation Engine Powers Ahead, but Its Business Model Faces Mounting Strain
3 months ago
prnewswire.com
Vi Releases 2026 State of AI Reports, Defining the New Performance Standard for Healthcare, Biopharma, and Wellness
3 months ago
prnewswire.com
Scinai CEO Amir Reichman to Co-Lead Manufacturers Association Biopharma Manufacturing Roundtable at HealthIL
3 months ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.